Thomas Gedulig, DO
Pain Medicine · Yakima, WANPI 1316367097
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. Medtronic accounts for 63.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $5,048 and has fallen 77.4% since, to $1,141 in 2025.
Across 93 payments — averaging $135.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$2K
- Boston Scientific$969
- Nalu Medical, Inc.$756
- SPR Therapeutics, Inc$279
- Avanos Medical$265
- plus $328 from 3 others
What the payments were for
- Consulting fees$80%
- Grants$3,00024%
- Travel & lodging$5,60344%
- Food & beverage$3,99032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 50 | $7,965 |
| Abbott | 16 | $2,039 |
| Boston Scientific | 7 | $969 |
| Nalu Medical, Inc. | 5 | $756 |
| SPR Therapeutics, Inc | 3 | $279 |
| Avanos Medical | 6 | $265 |
| Heron Therapeutics, Inc. | 2 | $170 |
| Nevro Corp. | 3 | $146 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$3,803
- SYNCHROMEDII$3,000
- PROCLAIM$1,581
- GENERAL - THERAPIES$875
- Nalu Neurostimulation System$628
How this compares
$12,601 in reported general payments places this provider in the 85th percentile of 124 pain medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 80 | $21,309 |
| Pregabalin | 201 | $3,409 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $1,974 |
| Gabapentin | 158 | $1,891 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $1,834 |
| Duloxetine Hcl | 115 | $1,698 |
| Baclofen | 111 | $1,245 |
| Oxycodone Hcl | 34 | $954 |
| Tramadol Hcl | 68 | $497 |
| Cyclobenzaprine Hcl | 20 | $405 |
| Tizanidine Hcl | 38 | $380 |
| Methocarbamol | 28 | $356 |
| Topiramate | 35 | $125 |
| Nortriptyline Hcl | 17 | $123 |
| Methylprednisolone | 17 | $118 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Yakima
- Daniel KwonYakima$2K
- Jennifer LeeKirkland$318K
- Steven StanosSeattle$206K
- Corrie AndersonSeattle$102K
- Gregory TermanSeattle$95K
- Caroline HarstroemEverett$74K
- Sloane YuVancouver$42K
- Praveen MambalamEdmonds$32K
- Miroslav BackonjaSeattle$22K
- Ross VogelgesangOlympia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.